Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0000899243-21-024990

Options or other derivatives

  • Director acquired 23,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kender Richard N · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-06-16 Grant or award : show line 1 in the form Stock Option (right to buy) +23,000 23,000 D
Loading xslF345X03/doc4.xml…